In an era defined by rapid advancements in pharmaceuticals and healthcare, ensuring the safety and efficacy of drugs is paramount. The global pharmacovigilance and drug safety software market is ...

Investing in AI tools for predictive analytics will be crucial in shaping the next phase of drug safety measures ...

Maturity level 3 is the key benchmark for global recognition - it demonstrates that a country has established a reliable ...

Attention deficit hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder. Despite its significance, no large-scale epidemiological study assessing ADHD, and its associated ...

Current clinical practice lacks quantitative assessment methods for elbow joint movements. In response to existing research limitations, this study introduces the innovative elbow joint torque ...

ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, today announced that another top-tier pharmaceutical ...

ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, today announced ...

Months after policy freeze, the DTAB is reconstituted to take up pending issues like AMR, GMP, spurious drugs and ...

Pharmacovigilance evolves with technology, employing active surveillance to detect drug-related issues and ensure safety in ...

This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies ...

The AI in pharmacovigilance market is expected to grow at a CAGR of 12–15% from 2023 to 2030, driven by the need to automate adverse event data processing, stringent regulatory requirements, ...